Notch3 Is Necessary for Blood Vessel Integrity in the Central Nervous System

Objective—Vascular smooth muscle cells (VSMC) are important for contraction, blood flow distribution, and regulation of blood vessel diameter, but to what extent they contribute to the integrity of blood vessels and blood–brain barrier function is less well understood. In this report, we explored the impact of the loss of VSMC in the Notch3−/− mouse on blood vessel integrity in the central nervous system. Approach and Results—Notch3−/− mice showed focal disruptions of the blood–brain barrier demonstrated by extravasation of tracers accompanied by fibrin deposition in the retinal vasculature. This blood–brain barrier leakage was accompanied by a regionalized and patchy loss of VSMC, with VSMC gaps predominantly in arterial resistance vessels of larger caliber. The loss of VSMC appeared to be caused by progressive degeneration of VSMC resulting in a gradual loss of VSMC marker expression and a progressive acquisition of an aberrant VSMC phenotype closer to the gaps, followed by enhanced apoptosis and cellular disintegration in the gaps. Arterial VSMC were the only mural cell type that was morphologically affected, despite Notch3 also being expressed in pericytes. Transcriptome analysis of isolated brain microvessels revealed gene expression changes in Notch3−/− mice consistent with loss of arterial VSMC and presumably secondary transcriptional changes were observed in endothelial genes, which may explain the compromised vascular integrity. Conclusions—We demonstrate that Notch3 is important for survival of VSMC, and reveal a critical role for Notch3 and VSMC in blood vessel integrity and blood–brain barrier function in the mammalian vasculature.

[1]  M. Graham,et al.  Notch signaling functions in retinal pericyte survival. , 2014, Investigative ophthalmology & visual science.

[2]  Stefan Ropele,et al.  Loss of Venous Integrity in Cerebral Small Vessel Disease: A 7-T MRI Study in Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) , 2014, Stroke.

[3]  C. Moens,et al.  Notch3 establishes brain vascular integrity by regulating pericyte number , 2014, Development.

[4]  J. Dauwerse,et al.  Hypomorphic NOTCH3 Alleles Do Not Cause CADASIL in Humans , 2013, Human mutation.

[5]  A. Joutel.  Loss‐of‐function Mutation in the NOTCH3 Gene: Simply a Polymorphism? , 2013, Human mutation.

[6]  L. Pantoni,et al.  Letter by Pescini et al regarding article, "Peripheral artery disease as a manifestation of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and practical implications". , 2013, Circulation.

[7]  A. Joutel,et al.  Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL. , 2013, Brain : a journal of neurology.

[8]  W. Talbot,et al.  notch3 is essential for oligodendrocyte development and vascular integrity in zebrafish , 2013, Disease Models & Mechanisms.

[9]  M. Bhattacharjee,et al.  Peripheral artery disease as a manifestation of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and practical implications. , 2013, Circulation.

[10]  Julie H. Campbell,et al.  Smooth muscle cell plasticity: fact or fiction? , 2013, Circulation research.

[11]  B. Lilly,et al.  Reciprocal Regulation of Syndecan-2 and Notch Signaling in Vascular Smooth Muscle Cells* , 2012, The Journal of Biological Chemistry.

[12]  G. Owens,et al.  Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. , 2012, Annual review of physiology.

[13]  Rickard Sandberg,et al.  Notch signaling: simplicity in design, versatility in function , 2011, Development.

[14]  C. Betsholtz,et al.  Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.

[15]  S. Gygi,et al.  Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease , 2011, Proceedings of the National Academy of Sciences.

[16]  A. Joutel.  Pathogenesis of CADASIL , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[17]  Bengt R. Johansson,et al.  Pericytes regulate the blood–brain barrier , 2010, Nature.

[18]  B. Barres,et al.  Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.

[19]  B. Barres,et al.  The Mouse Blood-Brain Barrier Transcriptome: A New Resource for Understanding the Development and Function of Brain Endothelial Cells , 2010, PloS one.

[20]  B. Lilly,et al.  Notch3 Is Critical for Proper Angiogenesis and Mural Cell Investment , 2010, Circulation Research.

[21]  A. Schedl,et al.  Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. , 2010, The Journal of clinical investigation.

[22]  B. Lilly,et al.  NOTCH3 Expression Is Induced in Mural Cells Through an Autoregulatory Loop That Requires Endothelial-Expressed JAGGED1 , 2009, Circulation research.

[23]  C. Baufreton,et al.  Notch3 Is a Major Regulator of Vascular Tone in Cerebral and Tail Resistance Arteries , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[24]  E. Larsson,et al.  Identification of a Core Set of 58 Gene Transcripts With Broad and Specific Expression in the Microvasculature , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[25]  Ulf Eriksson,et al.  Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke , 2008, Nature Medicine.

[26]  Fredrik Lanner,et al.  Notch Signaling Regulates Platelet-Derived Growth Factor Receptor-β Expression in Vascular Smooth Muscle Cells , 2008, Circulation research.

[27]  M. Moskowitz,et al.  Linking Notch signaling to ischemic stroke , 2008, Proceedings of the National Academy of Sciences.

[28]  K. Kaestner,et al.  Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development , 2008, Proceedings of the National Academy of Sciences.

[29]  Xiaoqin Zhu,et al.  NG2 cells generate both oligodendrocytes and gray matter astrocytes , 2007, Development.

[30]  T. Hastie,et al.  Gene Expression Programs of Human Smooth Muscle Cells: Tissue-Specific Differentiation and Prognostic Significance in Breast Cancers , 2007, PLoS genetics.

[31]  Holger Gerhardt,et al.  Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis , 2007, Nature.

[32]  G. Ransmayr,et al.  CADASIL—an unusual manifestation with prominent cutaneous involvement , 2005, The British journal of dermatology.

[33]  B. Klonjkowski,et al.  Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. , 2004, Genes & development.

[34]  A. Joutel,et al.  Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP/JK signaling Pathway. , 2004, American journal of human genetics.

[35]  U. Lendahl,et al.  A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Paul Scherz,et al.  Functional analysis of secreted and transmembrane proteins critical to mouse development , 2001, Nature Genetics.

[37]  C. Steidl,et al.  Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos , 2000, Mechanisms of Development.

[38]  J. Weissenbach,et al.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia , 1996, Nature.

[39]  C. Larsson,et al.  The human NOTCH1, 2, and 3 genes are located at chromosome positions 9q34, 1p13-p11, and 19p13.2-p13.1 in regions of neoplasia-associated translocation. , 1994, Genomics.

[40]  U. Lendahl,et al.  The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium , 1994, Mechanisms of Development.

[41]  A. Joutel,et al.  Autosomal Dominant Leukoencephalopathy and Subcortical Ischemic Stroke: A Clinicopathological Study , 1993, Stroke.

[42]  M. Dichgans,et al.  Letter by Dichgans et al regarding article, "Peripheral artery disease as a manifestation of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and practical implications". , 2013, Circulation.

[43]  C. Ayata,et al.  Genetic animal models of cerebral vasculopathies. , 2012, Progress in molecular biology and translational science.

[44]  M. A. Sheddi.  A clinicopathological study , 2012 .

[45]  S. Chien,et al.  Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. , 2011, Physiological reviews.

[46]  T. Gridley.  Notch signaling in the vasculature. , 2010, Current topics in developmental biology.

[47]  Justin Paul,et al.  Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease , 2007, The Journal of experimental medicine.